{"id":"W2032132548","doi":"10.1046/j.1468-3083.17.s2.4.x","title":"Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis","year":2003,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical trial; Body surface area; Dermatology; Internal medicine; Randomized controlled trial; Surgery; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003252321,0.001205098,0.002170047,0.0002758595,0.00049383,0.0007855918,0.0005513976,0.001188722,0.001278259],"category_scores_gemma":[0.002137801,0.0004839512,0.001282402,0.0003623882,0.0009072393,0.0004724077,0.0002525171,0.002006532,0.0004386272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008554693,"about_ca_system_score_gemma":0.001167481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001063562,"about_ca_topic_score_gemma":0.0009355529,"domain_scores_codex":[0.9987778,0.000634612,0.0000696772,0.0001892926,0.0001408653,0.0001877561],"domain_scores_gemma":[0.9980307,0.0005077779,0.0004521407,0.0001567246,0.0001433736,0.0007093472],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7523208,0.05423694,0.05999535,0.0003824715,0.00176986,0.0003625873,0.0004241863,0.001353538,0.03326341,0.0000548881,0.001971962,0.0938641],"study_design_scores_gemma":[0.4410706,0.3908888,0.1600371,0.00003665006,0.001002607,0.0006159847,0.00006641174,0.001387866,0.003320703,0.00007617238,0.001452713,0.0000442864],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969305,0.001554347,0.0002477173,0.000136109,0.00003127308,0.0004360105,0.0001903427,0.00003036021,0.0004434029],"genre_scores_gemma":[0.9971105,0.0005518008,0.0005636885,0.0002894329,0.0001194257,0.0003694379,0.0006458077,0.00001046023,0.0003394291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003252321,"threshold_uncertainty_score":0.01720017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02010016712135707,"score_gpt":0.2928549598225856,"score_spread":0.2727547927012285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}